Explore comprehensive CDMO services offered by Grifols International SA, supporting end-to-end Drug Development, Manufacturing and Packaging. Grifols International SA enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Spain
Description: Grifols International, S.A. is a leading global healthcare company specializing in the development, production, and distribution of plasma-derived medicines and biopharmaceutical products. Established in Barcelona, Spain in 1909, the company has since grown into the European leader and the third largest worldwide in the plasma-based products field. Grifols operates more than 390 donation centers globally, employs over 24,000 people, and maintains a direct presence in over 30 countries, serving patients in more than 110 regions around the world. The company’s primary focus includes therapeutic areas such as immunology, infectious diseases, pulmonology, hematology, neurology, and critical care. Key products include immunoglobulins, albumin, Factor VIII, Alpha-1 antitrypsin, antithrombin, and specialized hyperimmune immunoglobulins for conditions such as immunodeficiencies, hemophilia, genetic emphysema, and more. Grifols is also a recognized leader in transfusion medicine and clinical diagnostics, supplying devices, reagents, and instruments for clinical testing and blood safety enhancement. - Show More
